Zurich Cantonal Bank
RIGL icon

Zurich Cantonal Bank’s Rigel Pharmaceuticals RIGL Stock Holding History

Zurich Cantonal Bank’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-429
Closed -$18.4K – 3320
2025
Q4 		$18.4K Buy
+429
New +$16.2K ﹤0.01% 2468

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zurich Cantonal Bank's RIGL Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Rigel Pharmaceuticals (RIGL) stake by 89% in Q2 2026, buying an estimated $9.16K and bringing the position to 632 shares worth $24.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2475.

Zurich Cantonal Bank first reported a position in RIGL in Q2 2018 and has held it in 23 quarters since. The position peaked at $189K in Q2 2021. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Zurich Cantonal Bank held 632 shares of Rigel Pharmaceuticals worth $24.7K as of Q2 2026.
  • Zurich Cantonal Bank bought 297 Rigel Pharmaceuticals shares in Q2 2026, an estimated $9.16K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2475 holding.
  • Zurich Cantonal Bank first reported a position in Rigel Pharmaceuticals in Q2 2018 and has held it in 23 quarters since.
  • Zurich Cantonal Bank's Rigel Pharmaceuticals position peaked at $189K in Q2 2021.
  • 155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.